[1,2-a]

[1,2-b]

[1,2-c]

[1,2-d]

[1,2-f]

[1,2-x]

[1,5-a]

[1,5-b]

[1,5-c]

[1,5-d]

[1,6-ad][1,7-a]

[2,1-a]

[2,1-b]

[2,1-c]

[2,1-d]

[2,1-e]

[2,1-f]

[2,1-]

[2,3-a]

[2,3-b]

[2,3-c]

[2,3-d]

[2,3-e]

[2,3-f]

[2,3-g]

[2,3-h]

[2,3-ij][2,4-b]

[3,2-a]

[3,2-b]

[3,2-c]

[3,2-d]

[3,2-e]

[3,2-g]

[3,2-f]

[3,2-h]

[3,4-a]

[3,4-b]

[3,4-c]

[3,4-d]

[3,4-e]

[3,4-f]

[3,4-g]

[3,4-]

[4,3-a]

[4,3-b]

[4,3-c]

[4,3-d]

[4,3-e]

[4,3-g]

[4,3-]

[4,5-a]

[4,5-b]

[4,5-c]

[4,5-d]

[4,5-e]

[4,5-f]

[4,5-g]

[4,5-h]

[4,5-]

[5,1-a]

[5,1-b]

[5,1-c]

[5,1-f]

[5,1-]

[5,4-b]

[5,4-c]

[5,4-d]

[5,4-e]

[5,4-f]

[5,4-]

[5,6-b]

[5,6-c]

[5,6-]

[6,1-b]

[6,1-]

[6,5-b]

[6,5-]

Order 630384-20-2 Cyclopropanamine, 1-(4-iodophenyl)-

Order 88919-22-6 3-(2-Aminoethyl)-N-methyl-1H-indole-5-methanesulfonamide

Order 88919-51-1 N-DesMethyl SuMatriptan

Order 88920-24-5 (4-Methoxybenzyloxy)acetic acid

Order 13456-78-5 N,N,N,N-TETRABENZYL-P-PHENYLENEDIAMINE

Order 1345728-57-5 1-Benzyl-4-methyl-piperidine-4-carboxylic acid amide

Order 134574-95-1 3-Azabicyclo[3.1.0]hexane-1-methanamine, 3-(phenylmethyl)-

Order 134574-96-2 Carbamic acid, (3-azabicyclo[3.1.0]hex-1-ylmethyl)-, 1,1-dimethylethyl ester

Order 1345822-87-8 Sitagliptin EP Impurity B

Order 1346270-24-3 3-(5-Methylfuran-2-yl)-1H-pyrazole-5-carboxamide

Order 13462-93-6 AMMONIUM DIHYDROGEN ARSENATE

Order 13463-28-0 ERIOCITRIN

Order 13463-43-9 Ferrous sulfate monohydrate

Order 134637-67-5 1,3-DIBENZYLOXY-4,6-DINITROBENZENE

Order 142136-39-8 FULLERENE-C76, 98%

Order 1421372-66-8 AZD9291DA HCl salt

Order 1421372-67-9 1,4-BenzenediaMine,?N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]-2-nitro-

Order 1421372-94-2 N-(4-fluoro-2-Methoxy-5-nitrophenyl)-4-(1-Methylindol-3-yl)pyriMidin-2-aMine

Order 1421373-36-5 3-chloro-N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)propanamide

Order 1421373-62-7 Mutant EGFR inhibitor